Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent EC face a dramatic situation due to limited further treatment options. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Villafranca-Magdalena, Beatriz, Masferrer-Ferragutcasas, Carina, Lopez-Gil, Carlos, Coll-de la Rubia, Eva, Rebull, Marta, Parra, Genis, García, Ángel, Reques, Armando, Cabrera, Silvia, Colas, Eva, Gil-Moreno, Antonio, Moiola, Cristian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181722/
https://www.ncbi.nlm.nih.gov/pubmed/35682944
http://dx.doi.org/10.3390/ijms23116266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181722/
https://www.ncbi.nlm.nih.gov/pubmed/35682944
http://dx.doi.org/10.3390/ijms23116266

Ejemplares similares